Sulfur Burps on Semaglutide: Which Product Actually Fits?

Sulfur Burps on Semaglutide: Which Product Fits Slow Digestion, Gas, or Constipation?

Rotten-egg burps on semaglutide or tirzepatide tend to line up with one of three patterns: a slowed stomach, a shift in which gut bacteria ferment your meals, or stool backing up and fermenting longer than it should. The product that actually helps, an enzyme, a probiotic, or a fiber or laxative approach, depends on which pattern fits your timing.

Where the Rotten-Egg Smell Comes From

The smell itself is hydrogen sulfide, produced when gut bacteria ferment protein, particularly the sulfur-containing amino acids in meat, eggs, dairy, and cruciferous vegetables.¹ Most GLP-1 nutrition guidance has you eating more protein during weight loss, generally 1.2–1.6 g per kilogram of body weight a day, to protect muscle; sustained intake at or above roughly 2 g/kg a day is discouraged because of potential adverse health effects, not because of gas.² That higher protein target still means more of those sulfur-containing amino acids moving through your gut, which gives fermenting bacteria more raw material to work with. Semaglutide itself adds to the picture: in the trials behind Wegovy's label, belching was reported by 7% of people on the 2.4 mg dose over 68 weeks versus fewer than 1% on placebo.³ None of that tells you, on its own, whether your case is mostly a stomach problem, a bacteria problem, or a backed-up-bowel problem. Timing and triggers can point toward one of the three patterns below, but they're clues to raise with a clinician, not a diagnosis.

If They Hit Right After Eating: Slowed Digestion

If burping shows up within an hour or two of a meal, along with a stuffed, overly full feeling that lingers, a slowed stomach is the more likely driver. Semaglutide and tirzepatide both delay gastric emptying as part of how they work, and it's directly measurable: in a small, single-blind trial of women with PCOS and obesity on a lower semaglutide dose (1.0 mg weekly, not the 2.4 mg weight-management dose), four-hour stomach retention rose from about 7% at baseline to 37% after 12 weeks, versus 0% on placebo (P=.002).⁴ This effect seems to fade somewhat with continued use of long-acting GLP-1 drugs, though residual slowing has still been measured out to 16 weeks, and researchers say the data can't say what happens beyond that.⁵ The same review also found that how full or gassy someone feels correlates poorly with how slow their stomach actually is on a scan, so symptoms alone can't confirm this is your mechanism — it's a reasonable first guess based on timing, not a diagnosis.⁵

Digestive enzyme blends, taken with meals, target this driver directly. They supply amylase, protease, and lipase to help break down carbohydrate, protein, and fat before it has as much time to ferment. In a 60-day trial of Rome III–confirmed functional dyspepsia (fullness, early satiety, upper abdominal discomfort — not GLP-1 users), a five-enzyme blend outperformed placebo on all five symptom scales tested, each at P<.01 between groups.⁶ That's a related condition, not the same population, and the study's authors are the founders and employees of the company that makes the product.

A 2025 narrative review of supplements for people on GLP-1 drugs, written entirely by employees of a supplement retailer, cites no published trial testing any digestive enzyme product specifically in people taking these medications.⁷ If a slowed stomach looks like your pattern, an enzyme blend with meals is a reasonable, low-risk thing to try, dosed as a supplement rather than a drug, since it hasn't gone through the kind of premarket efficacy testing a prescription product would.

If They Happen No Matter What You Eat: A Gut Bacteria Shift

If burping isn't tightly tied to meal timing and shows up across a wide range of foods, including lower-protein meals, a shift in which bacteria dominate your colon is a more likely piece of the puzzle than gastric slowing on its own. Adding certain live strains, alongside a more diverse mix, is what's been tested here. In a six-week trial in healthy adults, a single strain, Bacillus subtilis BS50, improved burping scores in 44.7% of participants versus 22.2% on placebo (P=.041); that trial was funded by the strain's manufacturer, two of whose employees co-authored it and later filed a related patent application.⁸ A different combination, Bacillus coagulans paired with a separate enzyme blend, moved the needle on overall symptom burden (P=.048) and abdominal pain (P=.046) but didn't reach significance on its own gas or bloating subscales.⁹

WonderBiotics Probiotics for Gut Health is built for this exact driver. It pairs 60 billion CFU across 12 studied strains, including HN019, with a built-in five-enzyme blend (amylase, protease, lipase, cellulase, and lactase) and a small dose of the prebiotic FOS.¹⁰ We designed it to work on both fronts at once: a broader strain mix to shift what's fermenting, and enzymes to reduce how much undigested material reaches the colon in the first place, rather than betting everything on one ingredient.

HN019, the most-studied strain in that blend for bowel function, didn't separate from placebo on its own trial's predefined primary or secondary endpoints across 228 adults with constipation; the frequency improvement only showed up afterward, in a post-hoc subgroup of 65 people who started with fewer than three bowel movements a week (P=.01).¹¹ That trial was funded by the strain's manufacturer, two of whose employees were study authors. A separate meta-analysis pooling that trial with nine others found a significant overall benefit for probiotics over placebo, but it pooled all strains together rather than calculating an HN019-specific result, so it neither confirms nor rules out an effect for this particular strain.¹² And no placebo-controlled trial, of this product or any competitor, has tested whether any strain combination reduces sulfur burps specifically in people taking semaglutide or tirzepatide; the one registered trial pairing probiotics with GLP-1 treatment, in which the probiotic starts two weeks before semaglutide or tirzepatide, was still listed as not yet recruiting as of its most recent registry update.¹³ Whether a broader, multi-strain formula works better than a single strain for this specific symptom hasn't been tested either. The "3X relief" and "14-day" language on the label reflects what individual strains have shown in their own separate trials, not a clinical trial of this exact 12-strain, enzyme-added capsule, and none of it has been tested in a GLP-1 population specifically. We picked HN019 and the broader strain mix because they're among the more-studied options for this kind of symptom pattern, not because any single trial has proven they clear sulfur burps in GLP-1 users specifically; we position this as a reasonable first thing to try for a bacteria-driven pattern, not a guaranteed fix.

If They Ease Up After You Go: Constipation-Driven Fermentation

If burping is worst in the day or two before a bowel movement and noticeably better right after, stool is likely sitting in your colon longer than it should, giving bacteria more time to ferment it before it moves on. No trial has directly measured whether relieving constipation also relieves burping, but the underlying logic, less retention time, less fermentation, follows the same mechanism described above.¹ For this driver, the more directly tested products are soluble fiber first, with an osmotic laxative such as polyethylene glycol 3350 as a second step if fiber alone isn't enough.

Fiber's evidence here is solid, with one trade-off worth knowing upfront. Across a set of trials in adults with chronic constipation (not a GLP-1 population), fiber increased weekly bowel movements by about 1.19 on average, with psyllium alone adding roughly 3.08 per week.¹⁴ The same evidence base found fiber didn't meaningfully reduce bloating, but it significantly worsened flatulence in the short term (a standardized effect of 0.80, a large jump, P<.00001).¹⁴ Adding a big dose of fiber on day one, on top of burping you're already dealing with, can make gas worse before it makes you more regular.

Slower-fermenting fibers, such as wheat dextrin, produce less gas than fast-fermenting ones like inulin, with partially hydrolyzed guar gum falling in between, based on lab fermentation modeling rather than a head-to-head symptom trial.¹⁵ Starting with a small dose and increasing gradually, rather than jumping to a full serving, is the more comfortable way to use any fiber blend if gas is already a concern.

That's the logic behind our own WonderBiotics Daily Fiber Mix: most of the blend leans on slower-fermenting sources, Fibersol soluble corn fiber, partially hydrolyzed guar gum, and psyllium husk, alongside kale fiber, polydextrose, and white kidney bean powder, with only a small amount of FOS. It still isn't gas-free, since that FOS is fermentable, so the same start-low-and-build-up approach applies: one to three 6-gram sachets a day, working up as your gut adjusts rather than starting at the full dose.

HN019, the same strain in WonderBiotics Probiotics for Gut Health, also has transit-time data of its own: in a dose-ranging trial, the highest dose cut whole-gut transit time from 49 to 21 hours within that group over two weeks.¹⁶ That's a before-and-after change within one treatment arm, not a placebo-controlled comparison on that specific number. It's supporting context, not proof that this driver responds to the same product as the bacteria pattern above. If constipation is clearly your main driver, fiber or a gentle laxative has the more direct trial evidence for that piece specifically.

Most People Have More Than One Driver

Slowed gastric emptying and slowed colon transit are often part of the same overall GI slowdown from these medications, so it's common to recognize yourself in more than one of the three patterns above. If that's you, there's no rule against pairing an approach from more than one pattern, an enzyme with meals plus a small, gradual fiber increase, for example, but it's worth starting with whichever signal is clearest for you and giving it a few weeks before adding a second product. A registered dietitian or your prescriber can help you sort out which lever is doing the most work if it's genuinely unclear.

When to Call Your Doctor

Most GLP-1-related digestive changes, including sulfur burps, are uncomfortable rather than dangerous. A few patterns are not something to manage with a supplement. Severe or worsening abdominal pain that radiates to your back, along with nausea, vomiting, fever, or yellowing skin or eyes, needs care right away and can signal pancreatitis.¹⁷ Upper right abdominal pain lasting several hours together with fever, chills, jaundice, or dark urine points toward a gallbladder problem and also needs prompt medical attention.¹⁸ Severe abdominal pain, vomiting, or a new inability to pass gas or stool at all can signal a bowel obstruction and warrants emergency care.¹⁹ If you're having persistent or worsening GI symptoms on semaglutide or tirzepatide, don't stop or adjust your dose on your own; talk to your prescriber, who may be able to slow the pace of dose increases or otherwise adjust your plan.

References

1. Yao CK, Muir JG, Gibson PR. Review article: insights into colonic protein fermentation, its modulation and potential health implications. Aliment Pharmacol Ther. 2016;43(2):181-196. PMID 26527169.
2. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obes Pillars. 2025;15:100181. PMID 40673264.
3. Wegovy (semaglutide) Prescribing Information. DailyMed, Novo Nordisk. setid ee06186f-2aa3-4990-a760-757579d8f77b.
4. Jensterle M, Ferjan S, Ležaič L, et al. Semaglutide delays 4-hour gastric emptying in women with PCOS and obesity. Diabetes Obes Metab. 2023;25(4):975-984. PMID 36511825.
5. Jalleh RJ, Plummer MP, Marathe CS, et al. Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. J Clin Endocrinol Metab. 2025;110(1):1-15. PMC11651700.
6. Majeed M, Majeed S, Nagabhushanam K, et al. Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study. J Med Food. 2018;21(11):1120-1128. PMID 30156436.
7. Johnson BVB, Milstead M, Kreider R, Jones R. Dietary supplement considerations during glucagon-like peptide-1 receptor agonist treatment: A narrative review. Obes Pillars. 2025;16:100209. PMID 41368199.
8. Garvey SM, Mah E, Blonquist TM, Kaden VN, Spears JL. The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial. Gut Microbes. 2022;14(1):2122668. PMID 36269141.
9. Kalman DS, Schwartz HI, Alvarez P, Feldman S, Pezzullo JC, Krieger DR. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol. 2009;9:85. PMID 19922649.
10. WonderBiotics. Probiotics for Gut Health.
11. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation. Gut Microbes. 2018;9(3):236-251. PMID 29227175.
12. Garzon Mora N, Jaramillo AP. Effectiveness of Probiotics in Patients With Constipation: A Systematic Review and Meta-Analysis. Cureus. 2024;16(1):e52013. PMID 38344541.
13. Hospices Civils de Lyon. Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1). NCT07213323.
14. van der Schoot A, Drysdale C, Whelan K, Dimidi E. The Effect of Fiber Supplementation on Chronic Constipation in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Clin Nutr. 2022;116(4):953-969. PMID 35816465.
15. Noack J, Timm D, Hospattankar A, Slavin J. Fermentation Profiles of Wheat Dextrin, Inulin and Partially Hydrolyzed Guar Gum Using an In Vitro Digestion Pretreatment and In Vitro Batch Fermentation System Model. Nutrients. 2013;5(5):1500-1510. PMID 23645025.
16. Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. PMID 21663486.
17. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Symptoms & Causes of Pancreatitis.
18. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Symptoms & Causes of Gallstones.
19. Mayo Clinic. Intestinal obstruction - Symptoms and causes.